Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group. 2000

E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
Department of Medicine, University of California, San Francisco, 94143-0538, USA.

The three reported cases demonstrate that troglitazone is an idiosyncratic hepatotoxin that can lead to irreversible liver injury. Thus, troglitazone should be prescribed with caution and should not be used as a first-line agent in the treatment of type II DM when potentially less toxic alternatives are available. It remains to be seen whether the hepatotoxicity associated with troglitazone is a drug-class effect or specific to troglitazone. Other thiazolidinediones currently in clinical trials may be able to provide the therapeutic benefits of troglitazone without significant hepatotoxicity. If troglitazone is used, frequent monitoring of serum aminotransferases and symptoms is mandatory. However, as illustrated by these and other cases reported to date, the onset of troglitazone-induced liver injury is insidious and temporally variable. Thus, the value of close monitoring and when, if ever, it is safe to stop such monitoring are currently unclear.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077288 Troglitazone A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity. 5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione) - T,CS 045,CS-045,Prelay,Rezulin,CS045
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D017093 Liver Failure Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed) Hepatic Failure

Related Publications

E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
May 1992, Connecticut medicine,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
October 1987, Transplantation proceedings,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
November 2009, Transplantation proceedings,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
March 2003, The American journal of medicine,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
August 2001, Transplantation proceedings,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
March 2004, Journal of clinical gastroenterology,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
September 1971, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
June 1991, Transplantation proceedings,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
February 1989, Transplantation proceedings,
E J Murphy, and T J Davern, and A O Shakil, and L Shick, and U Masharani, and H Chow, and C Freise, and W M Lee, and N M Bass
July 1998, Annals of internal medicine,
Copied contents to your clipboard!